Advertisement
Other| Volume 38, ISSUE 3, Piii-iv, September 2018

Contributors

        Editor-In-Chief

        MILENKO JOVAN TANASIJEVIC, MD, MBA
        Vice Chair for Clinical Pathology and Quality, Department of Pathology, Director of Clinical Laboratories, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Associate Professor of Pathology, Harvard Medical School, Boston, Massachusetts, USA

        Editor

        GEZA S. BODOR, MD
        Professor, Department of Pathology, Director, Toxicology and TDM, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

        Authors

        GEZA S. BODOR, MD
        Professor, Department of Pathology, Director, Toxicology and TDM, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
        CORY BYSTROM, PhD
        Research and Development, Cleveland HeartLab, Cleveland, Ohio, USA
        ANDREW E. CLARK, PhD
        University of Arizona, Tucson, Arizona, USA
        CHRISTA M. COBBAERT, PhD
        Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center (LUMC), Leiden, The Netherlands
        ROBERT L. FITZGERALD, PhD, DABCC/T
        Professor, Department of Pathology, Director, Toxicology/Mass Spectrometry Laboratory, University of California, San Diego, University of California, San Diego Health System, Center for Advanced Laboratory Medicine, San Diego, California, USA
        UTTAM GARG, PhD
        Director, Division of Laboratory Medicine, Professor, Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, University of Missouri Health School of Medicine, Kansas City, Missouri, USA
        MARK S. LOWENTHAL, PhD
        Material Measurement Laboratory, Biomolecular Measurement Division, National Institute of Standards and Technology (NIST), Gaithersburg, Maryland, USA
        KARA L. LYNCH, PhD
        Associate Professor, Department of Laboratory Medicine, Clinical Laboratory, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA
        BRIAN A. RAPPOLD, PhD
        Laboratory Corporation of America, Durham, North Carolina, USA
        ALAN L. ROCKWOOD, PhD, DABCC
        Rockwood Scientific Consulting, Salt Lake City, Utah, USA
        JUDITH A. STONE, MT(ASCP), PhD, DABCC
        Senior Technical Specialist, Toxicology/Mass Spectrometry Laboratory, University of California, San Diego Health System, Center for Advanced Laboratory Medicine, San Diego, California, USA
        NICOLE V. TOLAN, PhD, DABCC
        Assistant Adjunct Professor, Pathology and Laboratory Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA; SCIEX Diagnostics, Director, Scientific and Medical Affairs, Framingham, Massachusetts, USA
        YURI E.M. VAN DER BURGT, PhD
        Department of Clinical Chemistry and Laboratory Medicine, Center for Proteomics and Metabolomics, Leiden University Medical Center (LUMC), Leiden, The Netherlands
        DONNA M. WOLK, MHA, PhD, D(ABMM)
        System Director, Clinical Microbiology, Diagnostic Medicine Institute, Department of Laboratory Medicine, Geisinger Health, Danville, Pennsylvania, USA; Wilkes University, Wilkes-Barre, Pennsylvania, USA